Association of platelet-to-lymphocyte ratio with sepsis based on MIMIC-IV database

  • Hui Zhao Zhejiang Xinan International Hospital, Department of Critical Care Medicine, Xiuzhou, Jiaxing, Zhejiang, China
  • Kai Wang Zhejiang Xinan International Hospital, Department of Critical Care Medicine, Xiuzhou, Jiaxing, Zhejiang, China
  • Zhiheng Li Zhejiang Xinan International Hospital, Department of Critical Care Medicine, Xiuzhou, Jiaxing, Zhejiang, China
  • Lili Mao Zhejiang Xinan International Hospital, Department of Critical Care Medicine, Xiuzhou, Jiaxing, Zhejiang, China
  • Jinli Miao Yangtze Delta Region Institute of Tsinghua University, The Yangtze River Delta Biological Medicine Research and Development Center of Zhejiang Province, Hangzhou, Zhejiang, China
  • Yan Sun Zhejiang Xinan International Hospital, Department of Critical Care Medicine, Xiuzhou, Jiaxing, Zhejiang, China
Keywords: biomarkers;, blood platelets;, intensive care unit;, lymphocytes;, mortality;, sepsis

Abstract


Background/Aim. Sepsis is a potentially lethal condition that ranks among the most severe medical disorders globally and results in elevated mortality rates. The aim of this study was to examine the correlation between sepsis outcomes in patients and the platelet-to-lymphocyte ratio (PLR), including mortality and duration of intensive care unit (ICU) stay from admission, while considering relevant demographic and clinical factors. Methods. In this retrospective study, the Medical Information Mart for Intensive Care (MIMIC)-IV dataset information was used. Sepsis patients were de-identified, and their PLR values were calculated upon admission. Multivariate logistic regression models were used to assess the relationship between PLR and mortality, adjusting for confounding variables such as age, gender, comorbidities, and vital signs. Additionally, the association between PLR and the length of the ICU stay was analyzed using linear regression models. Results. This study included 4,624 sepsis patients. Higher PLR values were significantly correlated with decreased survival probabilities in the unadjusted model [Model 1 – odds ratio (OR): 0.890, 95% confidence interval (CI): 0.810–0.970, p < 0.001]. This association remained significant after adjusting for demographic factors (Model 2 – OR: 0.920, 95% CI: 0.850–0.995, p < 0.001), comorbidities and biochemical parameters (Model 3 – OR: 0.880, 95% CI: 0.800–0.960, p = 0.0273), and vital signs (Model 4 – OR: 0.860, 95% CI: 0.780–0.940, p = 0.0301). Furthermore, our analyses revealed a trend towards prolonged ICU stay with higher PLR values, although the association did not reach statistical significance. Survivors were younger (median age 63.37 vs. 70.84 years) and had lower Charlson Comorbidity Index (CCI) scores (median CCI 4.00 vs. 6.00, p < 0.001) compared to non-survivors. Conclusion. The outcomes indicate that higher PLR levels correlate with greater fatality rates in sepsis patients, underscoring its potential as a predictive biomarker. The observed trend towards prolonged ICU stay with higher PLR warrants further investigation. Model 4, which includes demographic factors, comorbidities, biochemical parameters, and vital signs, demonstrated the strongest association between PLR and mortality, suggesting it may be the most clinically useful model for predicting sepsis outcomes. Incorporating PLR into risk assessment and therapeutic decision-making frameworks may enhance sepsis treatment and improve patient outcomes.

References

Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369(9): 840–51. Erratum in: N Engl J Med 2013; 369(21): 2069.

Gaieski DF, Edwards JM, Kallan MJ, Carr BG. Benchmarking the incidence and mortality of severe sepsis in the United States. Crit Care Med 2013; 41(5): 1167–74.

Póvoa P, Coelho L, Dal-Pizzol F, Ferrer R, Huttner A, Conway Morris A, et al. How to use biomarkers of infection or sepsis at the bedside: guide to clinicians. Intensive Care Med 2023; 49(2): 142–53.

Kriplani A, Pandit S, Chawla A, de la Rosette JJMCH, Laguna P, Jayadeva Reddy S, et al. Neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR) in predicting systemic inflammatory response syndrome (SIRS) and sepsis after percutaneous nephrolithot-omy (PNL). Urolithiasis 2022; 50(3): 341–8.

Biyikli E, Kayipmaz AE, Kavalci C. Effect of platelet-lymphocyte ratio and lactate levels obtained on mortality with sepsis and septic shock. Am J Emerg Med 2018; 36(4): 647–50.

Wang G, Mivefroshan A, Yaghoobpoor S, Khanzadeh S, Siri G, Rahmani F, et al. Prognostic Value of Platelet to Lymphocyte Ratio in Sepsis: A Systematic Review and Meta-analysis. Bio-med Res Int 2022; 2022: 9056363.

Zheng R, Shi YY, Pan JY, Qian SZ. Decrease in the Platelet-to-Lymphocyte Ratio in Days after Admission for Sepsis Corre-lates with In-Hospital Mortality. Shock 2023; 59(4): 553–9.

Shen Y, Huang X, Zhang W. Platelet-to-lymphocyte ratio as a prognostic predictor of mortality for sepsis: interaction effect with disease severity-a retrospective study. BMJ Open 2019; 9(1): e022896.

Pollard TJ, Johnson AEW, Raffa JD, Celi LA, Mark RG, Badawi O. The eICU Collaborative Research Database, a freely avail-able multi-center database for critical care research. Sci Data 2018; 5: 180178.

Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, An-nane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315(8): 801–10.

Van Vught LA, Wiewel MA, Hoogendijk AJ, Frencken JF, Sciclu-na BP, Klouwenberg PMC, et al. The host response in patients with sepsis developing intensive care unit-acquired secondary infections. Am J Respir Crit Care Med 2017; 196(4): 458–70.

Johnson AEW, Aboab J, Raffa JD, Pollard TJ, Deliberato RO, Celi LA, et al. A Comparative Analysis of Sepsis Identification Methods in an Electronic Database. Crit Care Med 2018; 46(4): 494–9.

Haddad DN, Mart MF, Wang L, Lindsell CJ, Raman R, Nord-ness MF, et al. Socioeconomic Factors and Intensive Care Unit-Related Cognitive Impairment. Ann Surg 2020; 272(4): 596–602.

Sarkar S, Kannan S, Khanna P, Singh AK. Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis. J Med Vi-rol 2022; 94(1): 211–21.

Simadibrata DM, Pandhita BAW, Ananta ME, Tango T. Platelet-to-lymphocyte ratio, a novel biomarker to predict the severity of COVID-19 patients: A systematic review and meta-analysis. J Intensive Care Soc 2022; 23(1): 20–6.

Mușat F, Păduraru DN, Bolocan A, Palcău CA, Copăceanu AM, Ion D, et al. Machine Learning Models in Sepsis Outcome Pre-diction for ICU Patients: Integrating Routine Laboratory Tests-A Systematic Review. Biomedicines 2024; 12(12): 2892.

Published
2025/09/26
Section
Original Paper